NAVIDEA BIOPHARMACEUTICALS I's ticker is and the CUSIP is 63937X903. A total of 2 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $18,000 | -25.0% | 51,000 | -13.6% | 0.00% | – |
| Q3 2017 | $24,000 | -20.0% | 59,000 | 0.0% | 0.00% | – |
| Q2 2017 | $30,000 | +500.0% | 59,000 | +637.5% | 0.00% | – |
| Q1 2017 | $5,000 | -50.0% | 8,000 | -26.6% | 0.00% | – |
| Q3 2016 | $10,000 | -23.1% | 10,900 | -54.6% | 0.00% | – |
| Q2 2016 | $13,000 | -43.5% | 24,000 | 0.0% | 0.00% | – |
| Q1 2016 | $23,000 | -81.7% | 24,000 | -74.7% | 0.00% | -100.0% |
| Q4 2015 | $126,000 | -32.6% | 94,700 | +15.6% | 0.00% | -66.7% |
| Q3 2015 | $187,000 | -33.5% | 81,900 | -53.1% | 0.00% | -25.0% |
| Q2 2015 | $281,000 | +93.8% | 174,800 | +91.0% | 0.00% | +100.0% |
| Q1 2015 | $145,000 | +14400.0% | 91,500 | +22775.0% | 0.00% | – |
| Q4 2014 | $1,000 | -93.3% | 400 | -96.4% | 0.00% | – |
| Q3 2014 | $15,000 | +150.0% | 11,200 | +180.0% | 0.00% | – |
| Q2 2014 | $6,000 | -90.8% | 4,000 | -88.5% | 0.00% | -100.0% |
| Q1 2014 | $65,000 | +97.0% | 34,900 | +119.5% | 0.00% | – |
| Q4 2013 | $33,000 | -89.1% | 15,900 | -86.1% | 0.00% | -100.0% |
| Q3 2013 | $302,000 | +205.1% | 114,000 | +208.1% | 0.01% | +200.0% |
| Q2 2013 | $99,000 | – | 37,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 10,900 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 43 | $0 | 0.00% |